CHYLOTHORAX Pfennig Lane Animal Hospital 512-989-2222

Total Page:16

File Type:pdf, Size:1020Kb

CHYLOTHORAX Pfennig Lane Animal Hospital 512-989-2222 CHYLOTHORAX Pfennig Lane Animal Hospital 512-989-2222 Let us consider the chest cavity for a moment. The chest can also be called the “thorax” and the chest cavity is sometimes called the “thoracic cavity.” The thorax houses the lungs and heart. There are some other structures present as well such as nerves, large blood vessels, and other conduits (such as the esophagus transporting food through the chest and into the stomach on the abdominal side of the diaphgragm) but the main residents of the chest are the heart and lungs. The lungs are the focus of this topic. The diaphragm and rib muscles extend and contract to draw breath into the lungs and expel it again. The lungs are like sponges filled with air instead of fluid and life depends on their ability to expand and contract normally. There is not a lot of extra room inside the chest so when something starts taking up space in the chest, the lungs cannot inflate to their natural extent. It becomes hard work to breathe and the patient’s focus becomes expanding the lung against limited space, sort of like trying to blow up a balloon that is too tight. Fluid can accumulate in the chest. This is totally different from fluid accumulating in the lungs. Fluid in the lungs is more like drowning, with coughing and sputtering. Fluid in the chest cavity is just taking up space and keeping the lung from expanding. The problem is not so much coughing as working hard with all the muscles available to get enough air. TYPES OF FLUIDS There are many types of fluids that can accumulate in a body cavity. When the fluid is blood, the problem is called “hemothorax.” When the fluid is pus, the problem is called “pyothorax.” When the fluid is actually air, the problem is “pneumothorax.” When the fluid is lymph, the problem is called “chylothorax.” The fluid is milky when it is drained from the chest, its whiteness being from fat. Chylothorax respresents a special problem and requires special therapy. INITIAL TESTS The effort the patient is making to breathe will probably be the first sign of trouble and upon seeing this, your veterinarian is likely to recommend radiographs. Fluid in the chest will be obvious. From there, the chest will need to be tapped with a needle and the fluid drained. This will create some relief for the patient as the lung will once again be able to expand. The fluid will most likely need to be sent to the lab for testing to determine the fluid type. WHAT IS LYMPH? We all know what blood is. We all know that blood circulates in veins and arteries and is moved by the pumping action of the heart. In fact there is another circulatory system in the body: the lymphatic system. Lymph fluid represents extra fluid draining from between the cells of the body, gradually channeling into lymph vessels. The fluid is moved by the natural movement of the body and its muscles. Lymph circulates through lymph nodes where cells of the immune system are exposed to the “drift wood” of debris that the lymph fluid has picked up. In this way, the immune system “sees” infection, tumor cells, foreign organisms etc. Cells circulate the lymph fluid to help fight infection and eventually the lymph circulation ends by dumping into the bloodstream. Lymph fluid is full of fat because fat is absorbed into the lymphatic system (the “lacteals”) of the intestine after digestion. Lymphatic fluid (also called “chyle”) contains fat, water, and lymphocytes (cells of the immune system). When something goes wrong with the circulation of the lymph fluid, lymph fluid can accumulate in the chest. DIAGNOSIS: CHYLOTHORAX If there is a reason for the chyle build up, it is important to find that reason. Often (especially in the cat), the reason is heart disease. Heart disease generally interferes w/lymphatic drainage and circulation and leads to the build up. Tumors can interfere with lymphatic circulation. Any sort of mass or growth in the chest could also be responsible. If a cause can be found, then it should be addressed if possible. If no cause can be found then the condition is termed “idiopathic” and is simply managed. Cats are diagnosed with chylothorax approximately four times as often as dogs. DIAGNOSIS: IDIOPATHIC CHYLOTHORAX There are several options for treatment though they have pros and cons. The most conservative method is “medical management.” This means that whenever the patient seems to be having some distress, the chest fluid is drained. How often this is necessary is highly individual but every few weeks is a common interval. In time, after many taps, scarring can build up to cause the fluid to “loculate” which means that small pockets of fluid form rather than one drainable area. This makes tapping more difficult over time. A supplement that may help is called “rutin.” Rutin is available in vitamin stores and acts to stimulate cells called “macrophages” to carry away some of the fat in the chyle. In some individuals this supplement is very helpful in reducing the amount of chyle build up. A low fat diet is generally also used in conjunction with the above. Medical management such as this is often recommended before surgery as some cases of chylothorax will spontaneously resolve. Another treatment involves the use of "somatostatin," a chemical normally produced in the brain to regulate intestinal hormone and enzyme secretion. One of its effects is to reduce chyle flow through the thoracic duct. A commercial product is available and can be used in pets but its use should be considered somewhat experimental. More permanent solutions require surgery. Here are some procedures that have been recommended in the past: THORACIC DUCT LIGATION The thoracic duct is the largest lymph vessel and is present in the chest. In older times it was thought that chylothorax resulted from a tear in the duct, spilling lymph into the chest. This turns out generally not to be the case but ligation of the duct is successful in permanently resolving chylothorax in 50% of dogs undergoing surgery. Less than 40% of cats achieved resolution. In patients where surgery was not successful, fluid build up continued (though not always chyle, sometimes just watery fluid would return). PLEUROPERITONEAL SHUNTING This technique involves placement of a sort of a drain in the diaphragm so that fluid from the chest could drain into the belly where causes no harm. Shunts can be active (where there is a pump that can be manually compressed) or passive where normal breathing and motion moves the fluid. Complication rate is fairly high with this procedure (nearly 50%) and it has not been recommended for cats. It does yield an average of 20 months of symptom-free living in dogs. THORACIC DUCT LIGATION WITH PERICARDECTOMY This method appears to be the current treatment of choice. The pericardium is the fibrous sac containing the he art. When it is bathed in chyle, it becomes thickened and may be slightly constricting the low pressure right side of the heart. When the pericardium is stripped away, lymph may be able to circulate in more normal channels that it previously could not. When this procedure was combined with thoracid duct ligation, chylothorax permanently resolved in 100% of dogs and 80% of cats. The surgery is difficult and highly invasive (as one might imagine since it involves manipulation of the heart) and should be performed by a surgery specialist only. .
Recommended publications
  • Chylothorax After Left Side Pneumothorax Surgery Managed by OK-432 Pleurodesis: an Effective Alternative
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Available online at www.sciencedirect.com ScienceDirect Journal of the Chinese Medical Association 77 (2014) 653e655 www.jcma-online.com Case Report Chylothorax after left side pneumothorax surgery managed by OK-432 pleurodesis: An effective alternative Sheng-Yang Huang a, Chou-Ming Yeh b, Chia-Man Chou a,c,*, Hou-Chuan Chen a a Division of Pediatric Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, ROC b Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan, ROC c National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC Received June 13, 2013; accepted September 23, 2013 Abstract Chylothorax, a relatively rare complication of thoracic surgery, mostly occurs on the right side. We present a 16-year-old male who received thoracoscopic surgery for left spontaneous pneumothorax. Chylothorax developed on the postoperative 2nd day and resolved after diet control on the 4th day. Unfortunately, chylothorax recurred 2 weeks later. Chest drainage and nil per os with total parental nutrition were given but in vain. Thereafter, chemical pleurodesis with OK-432 was performed. Chylothorax resolved on the next day. The relevant literature is reviewed and possible pathogenesis clarified. Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved. Keywords: chylothorax; pleurodesis; pneumothorax 1. Introduction 2. Case Report Postoperative chylothorax is infrequent but potentially A 16-year-old male patient had the history of left chest pain life-threatening and time-consuming to manage. Associated for 5 days.
    [Show full text]
  • Section 8 Pulmonary Medicine
    SECTION 8 PULMONARY MEDICINE 336425_ST08_286-311.indd6425_ST08_286-311.indd 228686 111/7/121/7/12 111:411:41 AAMM CHAPTER 66 EVALUATION OF CHRONIC COUGH 1. EPIDEMIOLOGY • Nearly all adult cases of chronic cough in nonsmokers who are not taking an ACEI can be attributed to the “Pathologic Triad of Chronic Cough” (asthma, GERD, upper airway cough syndrome [UACS; previously known as postnasal drip syndrome]). • ACEI cough is idiosyncratic, occurrence is higher in female than males 2. PATHOPHYSIOLOGY • Afferent (sensory) limb: chemical or mechanical stimulation of receptors on pharynx, larynx, airways, external auditory meatus, esophagus stimulates vagus and superior laryngeal nerves • Receptors upregulated in chronic cough • CNS: cough center in nucleus tractus solitarius • Efferent (motor) limb: expiratory and bronchial muscle contraction against adducted vocal cords increases positive intrathoracic pressure 3. DEFINITION • Subacute cough lasts between 3 and 8 weeks • Chronic cough duration is at least 8 weeks 4. DIFFERENTIAL DIAGNOSIS • Respiratory tract infection (viral or bacterial) • Asthma • Upper airway cough syndrome (postnasal drip syndrome) • CHF • Pertussis • COPD • GERD • Bronchiectasis • Eosinophilic bronchitis • Pulmonary tuberculosis • Interstitial lung disease • Bronchogenic carcinoma • Medication-induced cough 5. EVALUATION AND TREATMENT OF THE COMMON CAUSES OF CHRONIC COUGH • Upper airway cough syndrome: rhinitis, sinusitis, or postnasal drip syndrome • Presentation: symptoms of rhinitis, frequent throat clearing, itchy
    [Show full text]
  • Chylothorax As Rare Manifestation of Pleural Involvement in Waldenström Macroglobulinemia: Mechanisms and Management
    210 Lymphology 49 (2016) 210-217 CHYLOTHORAX AS RARE MANIFESTATION OF PLEURAL INVOLVEMENT IN WALDENSTRÖM MACROGLOBULINEMIA: MECHANISMS AND MANAGEMENT G. Leoncini, C.C. Campisi, G. Fraternali Orcioni, F. Patrone, F. Ferrando, C. Campisi Unit of Thoracic Surgery (GL), Unit of General & Lymphatic Surgery - Microsurgery and Department of Surgical Sciences and Integrated Diagnostics (DISC) (CCC,CC), Unit of Pathology (GFO), Unit of Internal Medicine and Medical Oncology and Department of Internal Medicine (DIMI) (FP,FF), IRCCS San Martino University Hospital - National Institute for Cancer Research, and University School of Medicine and Pharmaceutics, Genoa, Italy ABSTRACT increase of IgM level. Pleuropulmonary involvement is reported to be rare (from 0 Here we report the clinical, pathological, to 5% of cases), and it usually occurs during and immunological features of a rare case of the late phase of the disease (3,4). In such a Waldenström macroglobulinemia (WM) with scenario, chylothorax is rarely observed in pleural infiltrations. An atypical chylothorax, WM patients; indeed only seven cases have successfully treated by videothoracoscopy, been reported in the literature (5-11). We represented the main clinical feature of this report the case of a 66-year old man with the case of low-grade lymphoplasmacytic main clinical presentation of pleural lymphoma. Pleuropulmonary manifestations infiltrations with right chylothorax following are rare (from 0 to 5% of cases) in WM, with immunochemotherapy. An extra-bone chylothorax observed in just seven patients marrow involvement was suggested by both worldwide. In addition to describing this pleural fluid examination and multiple uncommon clinical presentation, we investi- pleural biopsies in parallel with a marked gate hypothetical pathogenetic mechanisms decrease of bone marrow (BM) participation causing chylothorax and through an up-to- (tumor cells in BM from 70% to 8%).
    [Show full text]
  • Modern Management of Traumatic Hemothorax
    rauma & f T T o re l a t a m n r e u n o t J Mahoozi, et al., J Trauma Treat 2016, 5:3 Journal of Trauma & Treatment DOI: 10.4172/2167-1222.1000326 ISSN: 2167-1222 Review Article Open Access Modern Management of Traumatic Hemothorax Hamid Reza Mahoozi, Jan Volmerig and Erich Hecker* Thoraxzentrum Ruhrgebiet, Department of Thoracic Surgery, Evangelisches Krankenhaus, Herne, Germany *Corresponding author: Erich Hecker, Thoraxzentrum Ruhrgebiet, Department of Thoracic Surgery, Evangelisches Krankenhaus, Herne, Germany, Tel: 0232349892212; Fax: 0232349892229; E-mail: [email protected] Rec date: Jun 28, 2016; Acc date: Aug 17, 2016; Pub date: Aug 19, 2016 Copyright: © 2016 Mahoozi HR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Hemothorax is defined as a bleeding into pleural cavity. Hemothorax is a frequent manifestation of blunt chest trauma. Some authors suggested a hematocrit value more than 50% for differentiation of a hemothorax from a sanguineous pleural effusion. Hemothorax is also often associated with penetrating chest injury or chest wall blunt chest wall trauma with skeletal injury. Much less common, it may be related to pleural diseases, induced iatrogenic or develop spontaneously. In the vast majority of blunt and penetrating trauma cases, hemothoraces can be managed by relatively simple means in the course of care. Keywords: Traumatic hemothorax; Internal chest wall; Cardiac Hemodynamic response injury; Clinical manifestation; Blunt chest-wall injuries; Blunt As above mentioned the hemodynamic response is a multifactorial intrathoracic injuries; Penetrating thoracic trauma response and depends on severity of hemothorax according to its classification.
    [Show full text]
  • Treatment of Hemothorax in the Era Of€The€Minimaly Invasive Surgery
    Mil. Med. Sci. Lett. (Voj. Zdrav. Listy) 2019, 88(4), 180-187 ISSN 0372-7025 (Print) ISSN 2571-113X (Online) DOI: 10.31482/mmsl.2019.011 Since 1925 REVIEW ARTICLE TREATMENT OF HEMOTHORAX IN THE ERA OF THE MINIMALY INVASIVE SURGERY Radek Pohnán 1,2 , Šárka Blažková 2, Vladislav Hytych 2, Petr Svoboda 1, Michal Makeľ 1, Iva Holmquist 3,4 and Miroslav Ryska 1 1 Department of Surgery, Central Military Hospital – Faculty Military Hospital, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic 2 Department of Thoracic Surgery, Thomayer's Hospital, 140 59 Prague, Czech Republic 3 Emory University Hospital Midtown, Maternity Center, Atlanta, Georgia, USA 4 Department of Epidemiology, Faculty of Health Sciences, University of Defence, Hradec Kralove, Czech Republic Received 19th July 2018. Accepted 13th May 2019. On-line 6th December 2019. Summary Hemothorax is a frequent clinical situation often associated with chest injury or with iatrogenic lesions. Spontaneous hemothorax is uncommon and among its cause may include coagulation disorders, pleural, pulmonary or vascular pathology. Diagnostics is based on radiography or ultrasound and thoracentesis which may be also therapeutic solution. The majority of hemothoraxes can be managed non-operatively but hemodynamic instability, the volume of evacuated blood and persisting blood loss or persisting hemothorax require surgery. A surgical approach may vary from open thoracotomy to rapidly developing minimally invasive methods - video-assisted thoracoscopic surgery (VATS) and videothoracoscopy (VTS). Key words: hemothorax; surgery; VATS; thoracotomy Introduction Hemothorax is a pathological collection of the blood within the pleural cavity. Hemothorax most frequently origin in a thoracic injury but the exact incidence is not known.
    [Show full text]
  • Pulmonary Hypertension As a Rare Cause of Postopera- Tive Chylothorax
    TEHRAN HEART CENTER Case Report Pulmonary Hypertension as a Rare Cause of Postopera- tive Chylothorax Feridoun Sabzi, MD*, Samsam Dabiri, MD, Alireza Poormotaabed, MD Kermanshah University of Medical Sciences, Imam Ali Hospital, Kermanshah, Iran. Received 13 August 2012; Accepted 16 December 2013 Abstract Chylothorax in adult occurs most commonly in the wake of cardiac and thoracic procedures. Injuries to the common thoracic duct in the thorax or its branches in the mediastinum, injuries to the thymus tissues, dissection of the superior vena cava or ascending aorta, dissection of the aortic arch, disruption of the accessory lymphatics in the left or right thorax, and increased pressure in the systemic vein exceeding that of the thoracic duct (usually in the superior vena cava thrombosis, Glenn Shunt, and hemi-Fontan) have been proposed as the possible causes of chylothorax after surgery for congenital heart disease. However, pulmonary hypertension is an exceedingly rare cause of chylothorax in adults. We present a case of chylothorax after atrial septal defect surgery in a 30-year-old female patient with pulmonary hypertension. The postoperative period was complicated by chylothorax, which was confirmed by the high lipid content of chylous effusion. The patient was treated conservatively with diet therapy, and the effusion was abolished completely after two weeks. No recurrence of chylothorax was detected at 3 months' follow-up. J Teh Univ Heart Ctr 2014;9(2):93-96 This paper should be cited as: Sabzi F, Dabiri S, Poormotaabed A. Pulmonary Hypertension as a Rare Cause of Postoperative Chylothorax. J Teh Univ Heart Ctr 2014;9(2):93-96.
    [Show full text]
  • A Case of Chronic Cavitary Pulmonary Aspergillosis Misdiagnose
    Misled by significant peripheral eosinophilia and travel history: a case of chronic cavitary pulmonary Aspergillosis misdiagnosed as a ruptured Echinococcus cyst Whitney Elg-Salsman,DO; Anna Brady, MD Oregon Health & Science University [ ] Introduction Imaging Discussion Chronic cavitary pulmonary CT: LLL Aspergillosis can have a diverse cavitary AspergillosisDevelopment of(CPA) a New Practice is Model clinical presentation from non- lesion and characterized by cavitary new LLL invasive Allergic Pulmonary lesion(s), elevated IgG titers to ground glass Aspergillosis (ABPA), semi- Aspergillus +/- elevated total IgE opacities and invasive chronic cavitary consolidation and Aspergillus IgE. This case accompanied Aspergillosis to invasive. illustrates the importance of by a small Her clinical presentation has keeping Aspergillus infection on pleural aspects of both ABPA (allergic effusion the differential with significant asthma and total elevated IgE) pleural eosinophilia and cavitary and chronic, semi-invasive lung lesion cavitary Aspergillosis. Take Home Points Case Description [ ] References A 53-year-old non-smoking 1.1. [ ] Differential for pleural fluid woman with well controlled eosinophilia includes: allergic asthma presented to the infection (TB, fungal, hospital with three days of dyspnea parasite), malignancy, without infectious symptoms. She GMS stain: showing Aspergillus fungal HE stain: Thick fibrotic wall with a Eosinophilic granulomatosis reported prior travel including wild hyphae with uniform septated hyphae, dense eosinophilic
    [Show full text]
  • Shortness of Breath
    Christopher Taggart, MD St. Mary’s Medical Center, Department of Family Shortness of breath: Looking Medicine, Grand Junction, Colo beyond the usual suspects christopher.taggart@ sclhs.net COPD and pneumonia come to mind when a patient The authors reported no potential conflict of interest is short of breath. But the signs and symptoms detailed relevant to this article. here should lead you to suspect an uncommon cause. CASE u Joan C is a 68-year-old woman who presents to the of- PRACTICE RECOMMENDATIONS fice complaining of an enlarging left chest wall mass that ap- peared within the past month. She was treated for small-cell ❯ Consider diagnoses other lung cancer 11 years ago. She has a 45 pack-year smoking his- than asthma, COPD, heart failure, and pneumonia in tory (she quit when she received the diagnosis) and has heart patients with persistent or failure, which is controlled. Your examination reveals a large progressive dyspnea. C (5 cm) firm mass on her left chest wall. There is no erythema or tenderness. She has no other complaints. You recommend surgi- ❯ Avoid steroids in patients with acute pericarditis cal biopsy and refer her to surgery. because research shows Ms. C returns to your office several days later complaining that they increase the of new and worsening shortness of breath with exertion that be- risk of recurrence. B gan the previous day. The presentation is similar to prior asthma exacerbation episodes. She denies any cough, fever, chest pain, ❯ Consider anticoagulation with warfarin in patients with symptoms at rest, or hemoptysis. On exam she appears comfort- pulmonary arterial hyperten- able and not in any acute distress.
    [Show full text]
  • Spontaneous Chylothorax Following Septic Pulmonary Embolization
    Hindawi Case Reports in Pulmonology Volume 2020, Article ID 3979507, 3 pages https://doi.org/10.1155/2020/3979507 Case Report Spontaneous Chylothorax following Septic Pulmonary Embolization Michael Agustin , Michele Yamamoto, Chawat Tongma, Leslie Anne Chua, Michael Torres, and Scott Shay Guam Regional Medical City, 133 Route 3, Dededo Guam, USA 96929 Correspondence should be addressed to Michael Agustin; [email protected] Received 30 October 2019; Revised 19 January 2020; Accepted 12 February 2020; Published 22 February 2020 Academic Editor: Nobuyuki Koyama Copyright © 2020 Michael Agustin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Chylothorax is the occurrence of chyle (lymph) in the pleural cavity secondary to damage of the thoracic duct. It is a rare form of pleural effusion which appears as a milky white turbid fluid. Malignancy is the leading cause of nontraumatic chylothorax while inadvertent surgical injury to the thoracic duct is the major cause of traumatic chylothorax. We report a case of spontaneous left-side chylothorax following septic pulmonary embolization (SPE) with Methicillin-Resistant Staphylococcus aureus (MRSA). This is a rare case of a nonmalignant, nontraumatic, and nontuberculous spontaneous chylothorax which was conservatively treated with fibrinolysis and diet modification. 1. Introduction with no mediastinal hilar adenopathy and no pleural effu- sion. There was no pulmonary artery filling defect or cardiac The accumulation of lymph in the pleural space due to dam- filling defect. We did not see any symptoms suggestive of age or obstruction of the thoracic duct results in chylothorax.
    [Show full text]
  • Bilateral Pleural Effusions
    what-mcgrath_Layout 1 03/11/10 1:49 PM Page 1879 CMAJ Practice What is your call? Bilateral pleural effusions Emmet E. McGrath MB PhD, Chris Barber MD Previously published at www.cmaj.ca See also clinical image by Yang and Liu, page 1883 Figure 1: Chest radiograph and contrast-enhanced computed tomography scan of the thorax showing bilateral pleural effusion in a 50- year-old woman with diffuse large B-cell lymphoma. 50-year-old woman presented with a short history no history or clinical evidence of cardiac, liver or renal fail- of loss of weight and appetite, constipation, right- ure, thoracentesis was performed. Milky off-white to yellow A sided abdominal pain, unsteady gait and headache. fluid was aspirated (Figure 2). It had a protein level of 10 g/L, Physical examination revealed a soft nontender abdomen a lactate dehydrogenase level of 152 IU/L, a glucose level of with normal bowel sounds. The results of respiratory, car- 8.1 mmol/L and a normal pH level. In serum samples, the diovascular and neurologic examinations were normal, as total protein level was 48 (normal 60–85) g/L and the lactate were the findings of a colonoscopy. dehydrogenase level was 858 (normal 105–333) U/L. A computed tomography (CT) scan of the abdomen showed a large solid mass in the region of the superior What is your diagnosis? mesenteric vessels. A radiograph and CT scan of the thorax were normal. A contrast-enhanced CT scan of the brain a. Cardiac failure showed a large tumour on the left side of the posterior cra- b.
    [Show full text]
  • Thoracic Duct
    Somewhat short cases Cross Canada Rounds June 21, 2018 Connie Yang CASE 1 • Male toddler – Pulmonary valve stenosis with only trivial gradient across the pulmonary valve, left ventricular outflow tract obstruction – Suspicion of Noonan syndrome – Presented with hypoxemia and increased work of breathing – Chest x-ray showing a pleural effusion Details of case removed Investigations • Pleural fluid – Bloody in appearance – Bacterial, fungal, mycobacterial culture negative – Cell count: lymphocytes 98%, macrophages 2% • Lymphocytes not clonal, cytology negative – Glucose 4.2 – Protein 42, LDH 1308 (blood protein 63, LDH 866) – Triglycerides 8.89mmol/L • Pleural:Blood ratio Protein 0.67, LDH 1.5 Investigations • Pleural fluid – Bloody in appearance • CHYLOTHORAX • NON-BACTERIAL – Bacterial, fungal, mycobacterial culture negative INFECTION (TB) • MALIGNANCY – Cell count: lymphocytes 98%, macrophages 2% • CONNECTIVE TISSUE • Lymphocytes not clonal, cytology negative DISEASE – Glucose 4.2 – Protein 42, LDH 1308 (blood protein 63, LDH 866) – Triglycerides 8.89mmol/L OVER 1.24mmol/L EXUDATE • Pleural:Blood ratio Protein 0.67, LDH 1.5 - protein ratio>0.5 -LDH ratio> 0.6 CHYLOHEMOTHORAX - LDH >2/3 serum What is your differential diagnosis for a chylous effusion? DDx: Chylothorax in Children 1 Thoracic Duct High venous 2 pressure Congenital / Primary 3 lymphatic Adapted from JD Tutor Pediatrics. 2014, Wassel Pediatrics 2015, Faul AJRCCM 2000 DDx: Chylothorax in Children Thoracic Duct damage, 1 compression, erosion • Post-operative • Trauma • Malignancy
    [Show full text]
  • Effect of Antifibrotics on Short-Term Outcome After Bilateral Lung Transplantation a Multi- Centre Analysis
    ERJ Express. Published on April 20, 2018 as doi: 10.1183/13993003.00503-2018 Early View Research letter Effect of Antifibrotics on Short-Term Outcome after Bilateral Lung Transplantation A Multi- Centre Analysis Christopher Lambers, Panja M Boehm, Silvia Lee, Fabio Ius, Peter Jaksch, Walter Klepetko, Igor Tudorache, Robin Ristl, Tobias Welte, Jens Gottlieb Please cite this article as: Lambers C, Boehm PM, Lee S, et al. Effect of Antifibrotics on Short- Term Outcome after Bilateral Lung Transplantation A Multi-Centre Analysis. Eur Respir J 2018; in press (https://doi.org/10.1183/13993003.00503-2018). This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Copyright ©ERS 2018 Copyright 2018 by the European Respiratory Society. Effect of Antifibrotics on Short-Term Outcome after Bilateral Lung Transplantation A Multi-Centre Analysis Christopher Lambers, MD1; Panja M Boehm, BA BSc1; Silvia Lee, MD2; Fabio Ius, MD3; Peter Jaksch, MD1; Walter Klepetko, MD1; Igor Tudorache, MD3; Robin Ristl, PhD4; Tobias Welte, MD5, 6; Jens Gottlieb, MD5, 6 Affiliations: 1Division of Thoracic Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria; 2Division of Respiratory Medicine, Department of Internal Medicine II, Medical University of
    [Show full text]